Risk factors and mechanisms of hepatocarcinogenesis with special emphasis on alcohol and oxidative stress

被引:245
作者
Seitz, HK [1 ]
Stickel, F
机构
[1] Salem Med Ctr, Dept Med, D-69121 Heidelberg, Germany
[2] Salem Med Ctr, Lab Alcohol Res Liver Dis & Nutr, D-69121 Heidelberg, Germany
[3] Univ Bern, Inst Clin Pharmacol, CH-3010 Bern, Switzerland
关键词
acetaldehyde; cytochrome P4502E1; hepatitis; methyl group transfer; reactive oxygen species; retinoids;
D O I
10.1515/BC.2006.047
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hepatocellular cancer is the fifth most frequent cancer in men and the eighth in women worldwide. Established risk factors are chronic hepatitis B and C infection, chronic heavy alcohol consumption, obesity and type 2 diabetes, tobacco use, use of oral contraceptives, and aflatoxin-contaminated food. Almost 90% of all hepatocellular carcinomas develop in cirrhotic livers. In Western countries, attributable risks are highest for cirrhosis due to chronic alcohol abuse and viral hepatitis B and C infection. Among those with alcoholic cirrhosis, the annual incidence of hepatocellular cancer is 1-2%. An important mechanism implicated in alcohol-related hepa-tocarcinogenesis is oxidative stress from alcohol metabolism, inflammation, and increased iron storage. Ethanol-induced cytochrome P-450 2E1 produces various reactive oxygen species, leading to the formation of lipid peroxides such as 4-hydroxy-nonenal. Furthermore, alcohol impairs the antioxidant defense system, resulting in mitochondrial damage and apoptosis. Chronic alcohol exposure elicits hepatocyte hyperregeneration due to the activation of survival factors and interference with retinoid metabolism. Direct DNA damage results from acetaldehyde, which can bind to DNA, inhibit DNA repair systems, and lead to the formation of carcinogenic exocyclic DNA etheno adducts. Finally, chronic alcohol abuse interferes with methyl group transfer and may thereby alter gene expression.
引用
收藏
页码:349 / 360
页数:12
相关论文
共 136 条
[1]  
Albano E, 2002, ETHANOL AND THE LIVER: MECHANISMS AND MANAGEMENT, P153
[2]  
ALBANO E, 1993, ALCOHOL ALCOHOLISM, V28, P453
[3]  
Aleynik SI, 1998, ALCOHOL CLIN EXP RES, V22, P192, DOI 10.1111/j.1530-0277.1998.tb03637.x
[4]   Oxidants and antioxidants in alcohol-induced liver disease [J].
Arteel, GE .
GASTROENTEROLOGY, 2003, 124 (03) :778-790
[5]   Contribution of mitochondria to oxidative stress associated with alcoholic liver disease [J].
Bailey, SM ;
Cunningham, CC .
FREE RADICAL BIOLOGY AND MEDICINE, 2002, 32 (01) :11-16
[6]   THE RELATIONSHIP OF ETHANOL FEEDING TO THE METHYL FOLATE TRAP [J].
BARAK, AJ ;
BECKENHAUER, HC ;
HIDIROGLOU, N ;
CAMILO, ME ;
SELHUB, J ;
TUMA, DJ .
ALCOHOL, 1993, 10 (06) :495-497
[7]   The effect of ethanol-induced cytochrome p4502E1 on the inhibition of proteasome activity by alcohol [J].
Bardag-Gorce, F ;
Yuan, QX ;
Li, J ;
French, BA ;
Fang, C ;
Ingelman-Sundberg, M ;
French, SW .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 279 (01) :23-29
[8]   Oxidative stress and lipid peroxidation-derived DNA-lesions in inflammation driven carcinogenesis [J].
Bartsch, H ;
Nair, J .
CANCER DETECTION AND PREVENTION, 2004, 28 (06) :385-391
[9]   Neutrophilic infiltration in alcoholic hepatitis [J].
Bautista, AP .
ALCOHOL, 2002, 27 (01) :17-21
[10]   Prediction of risk of liver disease by alcohol intake, sex, and age: A prospective population study [J].
Becker, U ;
Deis, A ;
Sorensen, TIA ;
Gronbaek, M ;
BorchJohnsen, K ;
Muller, CF ;
Schnohr, P ;
Jensen, G .
HEPATOLOGY, 1996, 23 (05) :1025-1029